Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly those targeting cancer pathways. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in developing drugs for oncology. The compound's stereochemistry enhances selectivity, reducing off-target effects in cellular models. It is also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved metabolic stability and bioavailability.